Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 192

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 4A
Chunk 192
---
 of these variables with respect to the development, manufacture or commercialization enabling activities of any of our product candidates
would significantly change the costs, timing and viability associated with the development of that product candidate. For example, if
the FDA or another regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required
for the completion of clinical development of our Alpha DaRT technology and any potential future product candidate, or if we experience
significant delays in our clinical trials due to patient enrollment or other reasons, we would be required to expend significant additional
financial resources and time on the completion of clinical development.

Marketing expenses

Marketing expenses consist
primarily of salaries and other related costs, including share-based compensation, for personnel in marketing functions. Marketing expenses
also include direct and allocated facility-related costs as well as costs of participation in conferences and exhibitions, licenses for
marketing software, production of videos and marketing materials, and external consulting on product marketing or reimbursement.

We expect that our marketing
expenses will increase in the future to support continued marketing activities and potential commercialization of our Alpha DaRT technology
and any potential future product candidate. These increases will likely include increased costs related to the hiring of additional personnel
and fees to outside consultants, particularly if and when we initiate the hiring of a commercial team or increase our pre-launch commercial
activities.

General and administrative expenses

General and administrative
expenses consist primarily of salaries and other related costs, including share-based compensation, for personnel in executive, finance
and administrative functions. General and administrative expenses also include direct and allocated facility-related costs as well as
professional fees for legal, consulting, investor and public relations, accounting, auditing, tax services and insurance costs.

We expect that our general
and administrative expenses will increase in the future to support continued research and development activities and potential commercialization
of our Alpha DaRT technology and any potential future product candidate. These increases will likely include increased costs related to
the hiring of additional personnel and fees to outside consultants, attorneys and accountants, among other expenses.

Additionally, we expect to
continue to incur increased expenses associated with being a public company, including costs of additional personnel, accounting, audit,
legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and Securities and Exchange Commission
(“ SEC”) requirements, director and officer insurance costs, and investor and public relations costs.

Financial expenses (income), net

Financial expenses (income),
net, primarily consists of non-cash interest expense incurred on remeasurement of warrants